Portugal – Pharmaceutical products – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS]
Unidade Local de Saúde Santa Maria, E.P.E.
Buyer country
Portugal
Publication date
Not specified
Biderra sector
Health and medical
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 86%
- Official title coverage
- 7 languages
- Classification signal
- 33600000
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Portugal – Productos farmacéuticos – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS]
Portugal – Farmaceutische producten – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS]
Portugalia – Produkty farmaceutyczne – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS]
Portugal – Produits pharmaceutiques – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS]
Portugal – Arzneimittel – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS]
Portogallo – Prodotti farmaceutici – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS]
Portugal – Pharmaceutical products – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS]
What Biderra adds
For notice 393810-2026, Biderra has normalized the contracting authority country as Portugal, grouped CPV 33600000 under health and medical, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.